Research news

Researchers at IBEC help identifying a drug in clinical phase that blocks the effects of SARS-Co-V2

Researchers at the Institute for Bioengineering of Catalonia led by Professor ICREA Núria Montserrat have identified, in collaboration with experts from Karolinska Institute (Sweden), the Institute of Molecular Biotechnology of the Austrian Academy of Sciences and the Life Sciences Institute (LSI) at the University of British Columbia, among others, a treatment capable of blocking the effects of SARS-Co-V2,origin of the disease Coronavirus 2019, also known as COVID-19.

Read more…

Other news

Xavier Trepat receives the ERC Advanced Grant to lay the basis of a new generation of biological robots

The researcher at the Institute for Bioengineering of Catalonia (IBEC), Xavier Trepat, has received the prestigious ERC Advanced Grant awarded by the European Research Council (ERC) worth 2.5 million euros.

Thanks to this grant the expert and his group will be able to study the mechanical properties of the epithelium in 3D and to lay the foundations for a pioneering technology called “Epifluidics”, which will allow the design of biological robots.

Read more…